Inhibition of NF-B and metastasis in irinotecan (CPT-11)-resistant LoVo colon cancer cells by thymoquinone via JNK and p38

被引：40

作者：

Chen, Ming-Cheng ^{[1
]}

Lee, Nien-Hung ^{[2
]}

Hsu, Hsi-Hsien ^{[3
,4
]}

Ho, Tsung-Jung ^{[5
]}

Tu, Chuan-Chou ^{[6
]}

Chen, Ray-Jade ^{[7
]}

Lin, Yueh-Min ^{[8
,9
]}

Viswanadha, Vijaya Padma ^{[10
]}

Kuo, Wei-Wen ^{[11
]}

Huang, Chih-Yang ^{[2
,12
,13
]}

机构：

[1] Taichung Vet Gen Hosp, Div Colorectal Surg, Taichung, Taiwan

[2] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan

[3] Mackay Mem Hosp, Div Colorectal Surg, Taipei, Taiwan

[4] Mackay Med, Nursing & Management Coll, Taipei, Taiwan

[5] China Med Univ, Beigang Hosp, Chinese Med Dept, Yunlin, Taiwan

[6] Armed Force Taichung Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan

[7] Taipei Med Univ, Sch Med, Dept Surg, Taipei, Taiwan

[8] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan

[9] Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan

[10] Bharathiar Univ, Dept Biotechnol, Coimbatore, Tamil Nadu, India

[11] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan

[12] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan

[13] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan

来源：

ENVIRONMENTAL TOXICOLOGY | 2017年 / 32卷 / 02期

关键词：

CPT-11-R LoVo colon cancer cells; JNK; NF-B; p38; Thymoquinone; FACTOR-KAPPA-B; PANCREATIC-CANCER; ANTITUMOR-ACTIVITY; ACTIVATION; DRUG; ADENOCARCINOMA; SUPPRESSION; EXPRESSION; RESISTANCE; THERAPIES;

D O I：

10.1002/tox.22268

中图分类号：

X [环境科学、安全科学];

学科分类号：

08 ; 0830 ;

摘要：

Clinically used chemotherapeutics can effectively eliminate most tumor cells. However, they cause unwanted side effects and result in chemoresistance. To overcome such problems, phytochemicals are now used to treat cancers by means of targeted therapy. Thymoquinone (TQ) is used to treat different cancers (including colon cancer) and is an NF-B inhibitor. Irinotecan resistant (CPT-11-R) LoVo colon cancer cell line was previous constructed by step-wise CPT-11 challenges to un-treated parental LoVo cells and expresses EGFR/IKK//NF-B pathway. TQ resulted in reduced total and phosphorylation of IKK/ and NF-B and decreased metastasis in CPT-11-R cells. TQ not only reduced activity of ERK1/2 and PI3K but also activated JNK and p38. Furthermore, TQ was also found to suppress metastasis through activation of JNK and p38. Therefore, TQ suppressed metastasis through NF-B inhibition and activation of JNK and p38 in CPT-11-R LoVo colon cancer cells. (c) 2016 Wiley Periodicals, Inc. Environ Toxicol 32: 669-678, 2017.

引用

页码：669 / 678

页数：10

共 50 条

[31] NF-κB and p38 inhibition augment apoptosis induced by selective cyclooxygenase-2 inhibitor in human lung cancer cells in vitro
Alam, M
Wang, JH
Qadri, SS
Coffey, JC
O'Donnell, AF
Aherne, T
Redmond, HP
ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S81 - S81
[32] Attenuation of TNF-α-Induced Inflammatory Injury in Endothelial Cells by Ginsenoside Rb1 via Inhibiting NF-κB, JNK and p38 Signaling Pathways
Zhou, Ping
Lu, Shan
Luo, Yun
Wang, Shan
Yang, Ke
Zhai, Yadong
Sun, Guibo
Sun, Xiaobo
FRONTIERS IN PHARMACOLOGY, 2017, 8
[33] NF-κB and p38 inhibition augment apoptosis induced by selective cyclooxygenase-2 inhibitor in human lung cancer cells in vitro
M. Alam
J. H. Wang
S. S. Qadri
J. C. Coffey
A. F. O'Donnell
T. Aherne
H. P. Redmond
Annals of Surgical Oncology, 2004, 11 : S81 - S81
[34] TAK1, a target gene of miR-143, promotes proliferation and migration in pancreatic cancer via JNK/p38 MAPK and NF-κB pathway
Huang, F. T.
Zhang, S. N.
Zhuan-Sun, Y. X.
Tang, J.
Cheng, W. J.
Peng, J. F.
Zhuang, Y. Y.
Gu, Z. Q.
Chen, W. Y.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 141 - 141
[35] HNO suppresses LPS-induced inflammation in BV-2 microglial cells via inhibition of NF-κB and p38 MAPK pathways
Zhou, Yebo
Wu, Zhiyuan
Cao, Xu
Ding, Lei
Wen, ZhengShun
Bian, Jin-Song
PHARMACOLOGICAL RESEARCH, 2016, 111 : 885 - 895
[36] Galectin-1 induces metastasis and epithelial-mesenchymal transition (EMT) in human ovarian cancer cells via activation of the MAPK JNK/p38 signalling pathway
Zhu, Jie
Zheng, Ya
Zhang, Haiyan
Liu, Yanmei
Sun, Hong
Zhang, Pengnan
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (06): : 3862 - 3878
[37] RETRACTED: Berberine inhibits human gastric cancer cell growth via deactivation of p38/JNK pathway, induction of mitochondrial-mediated apoptosis, caspase activation and NF-κB inhibition (Retracted Article)
Wang, Yue
Zhou, Mingyin
Shang, Dong
JOURNAL OF BUON, 2020, 25 (01): : 314 - 318
[38] X-rays induced IL-8 production in lung cancer cells via p38/MAPK and NF-κB pathway
Song, Ying-Hui
Chai, Qin
Wang, Ni-la
Yang, Fan-Fan
Wang, Gui-Hua
Hu, Jin-Yue
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2020, 96 (11) : 1374 - 1381
[39] β-carotene attenuates lipopolysaccharide-induced inflammation via inhibition of the NF-κB, JAK2/STAT3 and JNK/p38 MAPK signaling pathways in macrophages
Li, Ruonan
Hong, Pan
Zheng, Xin
ANIMAL SCIENCE JOURNAL, 2019, 90 (01) : 140 - 148
[40] Newly Synthesized 'Hidabeni' Chalcone Derivatives Potently Suppress LPS-Induced NO Production via Inhibition of STAT1, but Not NF-κB, JNK, and p38, Pathways in Microglia
Hara, Hirokazu
Ikeda, Ryoko
Ninomiya, Masayuki
Kamiya, Tetsuro
Koketsu, Mamoru
Adachi, Tetsuo
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2014, 37 (06) : 1042 - 1049

← 1 2 3 4 5 →